Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.
Pascal Hammel
Honoraria - Roche
Florence Huguet
Honoraria - Roche
Jean-Luc Van Laethem
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Pascal Artru
Consultant or Advisory Role - Roche
Honoraria - Roche
Ivan Borbath
No relevant relationships to disclose
Olivier Bouche
Consultant or Advisory Role - Roche
Jenny Shannon
No relevant relationships to disclose
Thierry André
Consultant or Advisory Role - Roche
Honoraria - Roche
Laurent Mineur
No relevant relationships to disclose
Benoist Chibaudel
No relevant relationships to disclose
Franck Bonnetain
No relevant relationships to disclose
Christophe Louvet
No relevant relationships to disclose